A retained sample is material deliberately kept so it can be examined later. It can make a quality question investigable after the original testing is finished. Its value depends on knowing what was retained, how it relates to the batch and what happened to it during storage.
Distinguish a reserve from a stability study
ICH Q7 describes reserve samples as supporting potential future batch-quality evaluation and distinguishes that purpose from stability testing. This is a pharmaceutical quality-system example, not a claim about Novum’s retention arrangements.ICH Q7 — Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (opens in a new tab)
An investigation reserve is kept in case a later question arises. A stability study is designed around defined conditions, intervals and measurements to examine change over time. Keeping a vial on a shelf does not by itself create that study.
| Material | Main interpretation limit |
|---|---|
| Planned retained sample | Its own selection and storage history |
| Returned customer vial | Events before and after return may differ |
| Remaining test solution | Preparation and solution ageing may matter |
| Stability-study unit | The assigned study conditions and time point |
Before comparing results, establish which of these materials is actually available. Calling them all a retained sample can hide differences that matter to the investigation.
Preservation changes what a comparison means
ICH Q7 discusses identified reserve material in packaging equivalent to, or more protective than, the marketed packaging. A deliberately protected reserve may therefore have a different exposure history from material that travelled through distribution.ICH Q7 — Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (opens in a new tab)
Consider an original case: a returned vial shows a new impurity while a sealed reserve from the same recorded lot does not. That contrast is useful, but it does not establish when the difference arose or who caused it.
Possible explanations include differences between original units, transport or storage exposure, preparation effects, and analytical differences. The investigation needs evidence that separates these possibilities rather than treating a passing reserve as the end of the question.
Check whether the reserve can answer the new question
A reserve selected for one analytical purpose may not be sufficient for a later, different test. The available amount, container history, previous openings and suitability of the remaining material affect what can still be established.
A previous assay may have consumed part of a vial. Testing what remains cannot directly recover the original total content unless the removed amounts and relevant losses are accounted for. A fresh concentration result is not automatically an original fill result.
Likewise, material pooled from several units cannot retrospectively identify which original unit contributed an unusual result. A reserve’s usefulness follows the information preserved when it was created.
Plan the comparison around a specific question: whether a reported impurity is present in retained material, whether two preparations agree, or whether a documented change can be reproduced. These are more informative objectives than a general request to test again.
Keep the conclusion and remaining uncertainty together
An interpretable investigation records the retained-sample identifier, original batch relationship, storage and opening history, analytical method, comparison material and reason for each test. These links help another reader understand why the result is relevant.
State both what the reserve showed and what remains unresolved. If transport history is unknown, say so; do not turn that gap into proof of mishandling. If the reserve and returned vial disagree, preserve both findings.
Availability is a factual question for the organisation holding material. This article describes the role of reserves and does not promise that a particular supplier has retained units or can perform a retrospective test.
Sources and further detail
- ICH Q7 — Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients (opens in a new tab)
Sections 11.70–11.72 read for the purpose and packaging of reserves. No jurisdiction-specific retention period or Novum operational claim is inferred.
Sources checked 19 September 2026. Worked examples are illustrative unless a supplied report is explicitly identified. This article has not undergone independent scientific peer review.